Outset Medical, Inc. Payments to Acquire Investments
Outset Medical, Inc. (OM) reported Payments to Acquire Investments of $41.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-06
- Outset Medical, Inc. payments to acquire investments for the quarter ending 2026-06-30 was $18.65M, a 67.47% decline year-over-year.
- Outset Medical, Inc. payments to acquire investments for the quarter ending 2026-03-31 was $22.89M, a 76.23% decline year-over-year.
- Outset Medical, Inc. payments to acquire investments for the quarter ending 2025-12-31 was $28.22M, a 361.35% increase year-over-year.
- Outset Medical, Inc. payments to acquire investments for the quarter ending 2025-09-30 was $40.09M, a 82.07% increase year-over-year.
- Outset Medical, Inc. payments to acquire investments for fiscal 2025 was $221.97M, a 41.76% increase from fiscal 2024.
- Outset Medical, Inc. payments to acquire investments for fiscal 2024 was $156.58M, a 9.11% decline from fiscal 2023.
- Outset Medical, Inc. payments to acquire investments for fiscal 2023 was $172.28M, a 34.03% decline from fiscal 2022.
- Outset Medical, Inc. payments to acquire investments for fiscal 2022 was $261.15M, a 46.36% increase from fiscal 2021.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $41.54M 10-Q · filed 2026-08-06 | $69.76M derived: sum of 3 quarters · filed 2026-08-06 | $109.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $22.89M 10-Q · filed 2026-05-07 | $51.12M derived: sum of 2 quarters · filed 2026-05-07 | $91.21M derived: sum of 3 quarters · filed 2026-05-07 | $148.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $28.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $68.32M derived: sum of 2 quarters · filed 2026-02-13 | $125.64M derived: sum of 3 quarters · filed 2026-08-06 | $221.97M 10-K · filed 2026-02-13 |
| 2025-09-30 | $40.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $97.42M derived: sum of 2 quarters · filed 2026-08-06 | $193.75M 10-Q · filed 2025-11-10 | $199.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $57.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $153.65M 10-Q · filed 2026-08-06 | $159.77M derived: sum of 3 quarters · filed 2026-08-06 | $181.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $96.33M 10-Q · filed 2026-05-07 | $102.45M derived: sum of 2 quarters · filed 2026-05-07 | $124.47M derived: sum of 3 quarters · filed 2026-05-07 | $154.26M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $6.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $28.14M derived: sum of 2 quarters · filed 2026-02-13 | $57.93M derived: sum of 3 quarters · filed 2026-02-13 | $156.58M 10-K · filed 2026-02-13 |
| 2024-09-30 | $22.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $51.81M derived: sum of 2 quarters · filed 2025-11-10 | $150.47M 10-Q · filed 2025-11-10 | $201.49M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $29.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $128.44M 10-Q · filed 2025-08-07 | $179.47M derived: sum of 3 quarters · filed 2026-02-13 | $202.88M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $98.65M 10-Q · filed 2025-05-08 | $149.67M derived: sum of 2 quarters · filed 2026-02-13 | $173.09M derived: sum of 3 quarters · filed 2026-02-13 | $202.79M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $51.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $74.44M derived: sum of 2 quarters · filed 2026-02-13 | $104.14M derived: sum of 3 quarters · filed 2026-02-13 | $172.28M 10-K · filed 2026-02-13 |
| 2023-09-30 | $23.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $53.12M derived: sum of 2 quarters · filed 2024-11-07 | $121.26M 10-Q · filed 2024-11-07 | $213.80M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $29.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $97.85M 10-Q · filed 2024-08-08 | $190.39M derived: sum of 3 quarters · filed 2025-02-28 | $225.99M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $68.15M 10-Q · filed 2024-05-09 | $160.69M derived: sum of 2 quarters · filed 2025-02-28 | $196.29M derived: sum of 3 quarters · filed 2025-02-28 | $264.59M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $92.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $128.14M derived: sum of 2 quarters · filed 2025-02-28 | $196.44M derived: sum of 3 quarters · filed 2025-02-28 | $261.15M 10-K · filed 2025-02-28 |
| 2022-09-30 | $35.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $103.90M derived: sum of 2 quarters · filed 2023-11-08 | $168.62M 10-Q · filed 2023-11-08 | $198.91M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $68.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $133.01M 10-Q · filed 2023-08-03 | $163.31M derived: sum of 3 quarters · filed 2024-02-21 | $189.05M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $64.71M 10-Q · filed 2023-05-04 | $95.01M derived: sum of 2 quarters · filed 2024-02-21 | $120.74M derived: sum of 3 quarters · filed 2024-02-21 | $217.36M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $30.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $56.03M derived: sum of 2 quarters · filed 2024-02-21 | $152.64M derived: sum of 3 quarters · filed 2024-02-21 | $178.43M 10-K · filed 2024-02-21 |
| 2021-09-30 | $25.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $122.34M derived: sum of 2 quarters · filed 2022-11-09 | $148.13M 10-Q · filed 2022-11-09 | $148.13M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $96.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $122.40M 10-Q · filed 2022-08-02 | $122.40M derived: sum of 3 quarters · filed 2023-02-13 | |
| 2021-03-31 | $25.79M 10-Q · filed 2022-05-05 | $25.79M derived: sum of 2 quarters · filed 2023-02-13 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $32.88M 10-K · filed 2023-02-13 | ||
| 2020-09-30 | $32.88M 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $91.88M 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |